Anteris Technologies Global (NASDAQ:AVR) Major Shareholder Purchases $2,454,344.00 in Stock

Key Points

• L1 Capital purchased 322,940 Anteris Technologies Global shares at $7.60 each, spending $2.45 million and increasing its ownership by 6.62% to 5.2 million shares.
• Anteris shares fell 2.1% to $7.61, while the company reported a quarterly loss of $0.30 per share and revenue of $1.01 million, both weaker than analyst expectations.
• Analyst sentiment remains a “Moderate Buy,” with an average price target of $16, although ratings range from Cantor Fitzgerald’s $15 overweight target to Weiss Ratings’ sell assessment.

Anteris Technologies Global Corp. (NASDAQ:AVR - Get Free Report) major shareholder L1 Capital Pty Ltd bought 322,940 shares of the firm's stock in a transaction on Thursday, October 1st. The shares were bought at an average cost of $7.60 per share, with a total value of $2,454,344.00. Following the transaction, the insider directly owned 5,200,767 shares of the company's stock, valued at approximately $39,525,829.20. This trade represents a 6.62% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Major shareholders that own more than 10% of a company's shares are required to disclose their transactions with the SEC.

L1 Capital Pty Ltd also recently made the following trade(s):

• On Wednesday, September 30th, L1 Capital Pty Ltd purchased 74,286 shares of Anteris Technologies Global stock. The shares were bought at an average price of $7.72 per share, for a total transaction of $573,487.92.
• On Friday, August 28th, L1 Capital Pty Ltd sold 7,800 shares of Anteris Technologies Global stock. The shares were sold at an average price of $8.83, for a total transaction of $68,874.00.
• On Tuesday, August 11th, L1 Capital Pty Ltd sold 375,815 shares of Anteris Technologies Global stock. The stock was sold at an average price of $9.30, for a total transaction of $3,495,079.50.
• On Monday, August 10th, L1 Capital Pty Ltd sold 251,844 shares of Anteris Technologies Global stock. The shares were sold at an average price of $9.10, for a total value of $2,291,780.40.
• On Thursday, August 6th, L1 Capital Pty Ltd sold 174,721 shares of Anteris Technologies Global stock. The stock was sold at an average price of $8.10, for a total value of $1,415,240.10.
• On Tuesday, August 4th, L1 Capital Pty Ltd sold 480,608 shares of Anteris Technologies Global stock. The shares were sold at an average price of $8.30, for a total value of $3,989,046.40.
• On Wednesday, August 5th, L1 Capital Pty Ltd sold 14,581 shares of Anteris Technologies Global stock. The shares were sold at an average price of $8.23, for a total value of $120,001.63.
• On Monday, August 3rd, L1 Capital Pty Ltd sold 475,693 shares of Anteris Technologies Global stock. The stock was sold at an average price of $8.10, for a total value of $3,853,113.30.
• On Friday, July 31st, L1 Capital Pty Ltd sold 48,711 shares of Anteris Technologies Global stock. The shares were sold at an average price of $8.15, for a total value of $396,994.65.
• On Wednesday, July 29th, L1 Capital Pty Ltd sold 155,505 shares of Anteris Technologies Global stock. The stock was sold at an average price of $8.04, for a total transaction of $1,250,260.20.

Anteris Technologies Global Trading Down 2.1%

NASDAQ:AVR traded down $0.16 during trading hours on Thursday, hitting $7.61. 1,170,680 shares of the company traded hands, compared to its average volume of 718,688. The stock has a market capitalization of $741.67 million, a price-to-earnings ratio of -3.90 and a beta of 1.87. Anteris Technologies Global Corp. has a twelve month low of $3.30 and a twelve month high of $11.06. The firm has a 50-day moving average of $8.51 and a 200 day moving average of $7.98.

Anteris Technologies Global (NASDAQ:AVR - Get Free Report) last issued its quarterly earnings results on Tuesday, August 11th. The company reported ($0.30) earnings per share for the quarter, missing analysts' consensus estimates of ($0.21) by ($0.09). Anteris Technologies Global had a negative net margin of 4,619.27% and a negative return on equity of 77.69%. The company had revenue of $1.01 million during the quarter, compared to the consensus estimate of $1.50 million. During the same period last year, the company earned ($0.58) earnings per share. Equities research analysts predict that Anteris Technologies Global Corp. will post -1.21 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on the stock. Weiss Ratings reiterated a "sell (d-)" rating on shares of Anteris Technologies Global in a research note on Wednesday, August 26th. Cantor Fitzgerald reissued an "overweight" rating and issued a $15.00 target price on shares of Anteris Technologies Global in a research note on Friday, August 14th. Four equities research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company's stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average price target of $16.00.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the company. BlackRock Inc. acquired a new stake in Anteris Technologies Global during the 2nd quarter valued at $56,846,000. Nantahala Capital Management LLC bought a new position in shares of Anteris Technologies Global in the second quarter valued at about $33,325,850. ADAR1 Capital Management LLC acquired a new position in Anteris Technologies Global during the 2nd quarter worth about $30,979,000. Perceptive Advisors LLC grew its holdings in Anteris Technologies Global by 104.4% during the 1st quarter. Perceptive Advisors LLC now owns 3,425,476 shares of the company's stock worth $19,011,000 after acquiring an additional 1,750,000 shares during the last quarter. Finally, Assenagon Asset Management S.A. acquired a new stake in Anteris Technologies Global in the 2nd quarter valued at about $6,350,000.

Anteris Technologies Global Company Profile

Anteris Technologies Global Corp. is a medical device company focused on developing advanced technologies for structural heart disease. Its primary product candidate is the DurAVR transcatheter heart valve, designed to treat aortic valve stenosis through a minimally invasive transcatheter aortic valve replacement procedure.

The DurAVR valve is based on Anteris' ADAPT tissue-engineering technology and is manufactured as a single-piece valve intended to replicate the performance and natural hemodynamics of a healthy human aortic valve.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.